Cardiovascular Risk Reclassification With the 2026 Dyslipidemia Guideline

Дата публикации: 18-08-2026 00:00:00

This study uses data from the National Health and Nutrition Examination Survey (NHANES) to evaluate the extent of cardiovascular risk reclassification from the 2013 pooled cohort equations (PCEs) to the 2023 Predicting Risk of Cardiovascular EVENTs (PREVENT-ASCVD) equations.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy	0	11.25	18-08-2026
2	Dyslipidemia Evaluation and Management	0	11.26	18-08-2026
3	Prevalence of LDL-C Above 2026 Dyslipidemia Guideline Goals Among US Adults	0	20.18	18-08-2026
4	New Dyslipidemia Guidelines Lower the Lipid Treatment Goals and Raise the Bar for Clinical Practice	0	6.02	18-08-2026
5	Global Burden of Elevated LDL-C	0	10.09	29-07-2026
6	Central adiposity may better guide CV risk assessment vs. BMI	0	6.26	11-08-2026
7	Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease	0	8.74	28-07-2026
8	1 in 5 people may carry this hidden genetic heart risk	0	10.98	10-08-2026
9	High LDL rising globally while associated mortality falls	0	15.14	07-08-2026
10	PMOS may raise risk for atherosclerotic heart disease	0	7.27	12-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.38. Источник: archderm.jamanetwork.com.